Showing 1 - 20 results of 24 for search 'James L. Januzzi', query time: 0.06s
Refine Results
-
1
-
2
-
3
A Biomarker‐Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy by Reza Mohebi, Roland van Kimmenade, Cian McCarthy, Hanna Gaggin, Roxana Mehran, George Dangas, James L. Januzzi
Published 2022-05-01
Article -
4
-
5
MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure by Aferdita Spahillari, Laurel Jackson, Dimitrios Varrias, Sam A. Michelhaugh, James L. Januzzi, Bobby Shahideh, David Daghfal, Nedyalka Valkov, Gillian Murtagh, Saumya Das
Published 2024-06-01
Article -
6
Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study by James L. Januzzi, Roland R. J. van Kimmenade, Yuxi Liu, Xingdi Hu, Auris Browne, Jorge Plutzky, Sotirios Tsimikas, Ron Blankstein, Pradeep Natarajan
Published 2024-06-01
Article -
7
-
8
-
9
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions by Gillian Murtagh, James L. Januzzi, Marielle Scherrer‐Crosbie, Tomas G. Neilan, Susan Dent, Jennifer E. Ho, Vinesh Appadurai, Ray McDermott, Nausheen Akhter
Published 2023-11-01
Article -
10
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan by Reza Mohebi, Yuxi Liu, Javed Butler, G. Michael Felker, Jonathan H. Ward, Margaret F. Prescott, Ileana L. Piña, Scott D. Solomon, James L. Januzzi Jr
Published 2023-10-01
Article -
11
Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial by Reza Mohebi, Yuxi Liu, Michael K. Hansen, Yshai Yavin, Naveed Sattar, Carol A. Pollock, Javed Butler, Meg Jardine, Serge Masson, Hiddo J. L. Heerspink, James L. Januzzi Jr
Published 2023-07-01
Article -
12
Home‐Time After Discharge Among Patients With Type 2 Myocardial Infarction by Cian P. McCarthy, Sean Murphy, Saad Rehman, Maeve Jones‐O'Connor, David S. Olshan, Joshua A. Cohen, Jinghan Cui, Avinainder Singh, Muthiah Vaduganathan, James L. Januzzi, Jason H. Wasfy
Published 2020-05-01
Article -
13
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial by Thomas H. Marwick, Carolyn Lam, Yuxi Liu, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, W. H. Wilson Tang, Faiez Zannad, Riccardo Perfetti, James L. Januzzi
Published 2025-01-01
Article -
14
Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus by Nasrien Ibrahim, Renata Mukai, Craig Magaret, Rhonda Rhyne, Grady Barnes, Roland R J van Kimmenade, James L Januzzi, Cian P McCarthy, Shreya Shrestha, Hanna K Gaggin, Joseph M Garasic
Published 2019-05-01
Article -
15
Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease by Tiffany R. Bellomo, Yuxi Liu, Thomas C. Gilliland, Hannah Miksenas, Sara Haidermota, Megan Wong, Xingdi Hu, Joaquim Rosado Cristino, Auris Browne, Jorge Plutzky, Sotirios Tsimikas, James L. Januzzi, Jr., Pradeep Natarajan
Published 2024-07-01
Article -
16
Cardiac troponin T in extracellular vesicles as a novel biomarker in human cardiovascular disease by Kathleen M. Lennon, Andras Saftics, Sarah Abuelreich, Parul Sahu, H. Immo Lehmann, Adam L. Maddox, Reem Bagabas, James L. Januzzi, Kendall Van Keuren‐Jensen, Ravi Shah, Saumya Das, Tijana Jovanovic‐Talisman
Published 2022-08-01
Article -
17
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial by James L. Januzzi, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Thomas Marwick, W. H. Wilson Tang, Yuxi Liu, Reza Mohebi, Alessia Urbinati, Faiez Zannad, Riccardo Perfetti
Published 2024-02-01
Article -
18
Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) stu... by James L Januzzi, Hanna K Gaggin, Megan Welch, Daniel A Zlotoff, Kevin Wei, Andrew Abboud, Austin Nguonly, Asher Bean, Kemar J Brown, Roy F Chen, David Dudzinski, Neyat Fiseha, Melvin Joice, Davis Kimaiyo, Mackenzie Martin, Christy Taylor
Published 2021-12-01
Article -
19
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause by Muhammad Shahzeb Khan, Javed Butler, Stefan D. Anker, Gerasimos Filippatos, João Pedro Ferreira, Stuart J. Pocock, James L. Januzzi, Ileana L. Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Published 2023-01-01
Article -
20
Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction by Melissa A. Daubert, Eric Yow, Huiman X. Barnhart, Ileana L. Piña, Tariq Ahmad, Eric Leifer, Lawton Cooper, Patrice Desvigne‐Nickens, Mona Fiuzat, Kirkwood Adams, Justin Ezekowitz, David J. Whellan, James L. Januzzi, Christopher M. O’Connor, G. Michael Felker
Published 2021-05-01
Article